MoCoSnow

The National Weather Service released its latest expected snowfall maps this morning with all of MoCo coming in on the 3-4” range.

In the images you’ll also see a “reasonable worst case scenario” map showing a possible 6-7” if there’s a boom scenario and a “low end amount” map that shows just over an inch area-wide.


MoCoSnow

A Winter Weather Advisory has been issued for areas near/east of the I-95 corridor for possible freezing rain between 4am and 9am tomorrow.

As of now, none of MoCo is under this advisory, but all of neighboring Prince George’s County is. A Special Weather Statement has been issued for MoCo.


Education

Earlier today in a media briefing, MCPS informed the public that it will be sorting schools into three categories– green, yellow, and red.

The categories will identify whether individual schools are below the 5% threshold (5% of the population of students and staff testing positive for Covid-19 in a 14 day period).


MoCoSnow

The National Weather Service provided a pretty good snow forecast for this morning’s storm, with most places very close to what was being projected for them.

Leading the way for MoCo was Somerset, an area near Bethesda that borders DC, with 8.5 inches. Areas in S/SE MoCo generally came in with the highest numbers, while northern areas that usually get the most snow came in with lower totals.


MCFRS

Several crashes have been reported across the county, according to tweets by MCFRS PIO Pete Piringer. Montgomery County remains on Blue Alert with over 25 of 43 available EMS transport units committed on calls or at the hospital.

12:45- NB I270 IAO prior to Montrose Rd, collision, single vehicle into a wall


Business

GAITHERSBURG, Md., Dec. 31, 2021 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has completed submission of the final data package, including the complete chemistry, manufacturing and controls module, to fulfill the prerequisites for emergency use authorization (EUA) application request to the U.S. Food and Drug Administration (FDA) for NVX-CoV2373, the company’s recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant. Novavax expects to submit a request for EUA for the vaccine in the U.S. in one month in accordance with guidance from the FDA regarding submission of all EUA vaccines.

“Novavax is committed to delivering our protein-based vaccine in the United States, where the COVID-19 pandemic continues to evolve with the emergence of new variants, ongoing need to ensure primary vaccination for the eligible population, and need for boosting,” said Stanley C. Erck, President and Chief Executive Officer, Novavax. “We thank the U.S. Government for its ongoing support of our COVID-19 vaccine program, as well as our clinical trial participants and those who have supported the development and manufacturing of our vaccine.”


View More Stories